These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 10174358)

  • 41. Does your physician network violate antitrust law?. Interview by Michael Pretzer.
    Pitofsky R
    Med Econ; 1996 Oct; 73(19):68-70, 73-6, 79. PubMed ID: 10162456
    [No Abstract]   [Full Text] [Related]  

  • 42. Physician practice integration and consolidation: an antitrust enforcement perspective.
    Wessler SL
    Int Ophthalmol Clin; 1998; 38(3):45-57. PubMed ID: 9742432
    [No Abstract]   [Full Text] [Related]  

  • 43. Mergers and health care organizations.
    Shaw DV
    J Health Care Finance; 2003; 29(3):28-37. PubMed ID: 12635992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitrust evaluation of physician networks.
    Rosen BF; Dietz RL
    Md Med J; 1996 Aug; 45(8):611-3. PubMed ID: 8772273
    [No Abstract]   [Full Text] [Related]  

  • 45. Are medical groups a threat to managed care organizations?
    Zwerner AR
    Med Interface; 1996 Oct; 9(10):60, 62. PubMed ID: 10161511
    [No Abstract]   [Full Text] [Related]  

  • 46. Dialogue. Industry consolidation: what's at stake for consumers and purchasers?
    Greenberg W; Allen J; Wider JJ; Ray CG
    Behav Healthc Tomorrow; 1998 Aug; 7(4):32-8. PubMed ID: 10182151
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Market therapy. Competition can be messy and expensive, but it benefits the patient.
    Burda D
    Mod Healthc; 2008 Mar; 38(13):19. PubMed ID: 18467989
    [No Abstract]   [Full Text] [Related]  

  • 48. Physician networks and their implications for competition in health care markets.
    Haas-Wilson D; Gaynor M
    Health Econ; 1998 Mar; 7(2):179-82. PubMed ID: 9565176
    [No Abstract]   [Full Text] [Related]  

  • 49. Integrated delivery systems ... managed care organizations, hospitals, doctors, and insurers are developing new entities to compete for business.
    Lopez L
    State Health Care Am; 1995; ():31-5. PubMed ID: 10168068
    [No Abstract]   [Full Text] [Related]  

  • 50. Formation of medical and hospital groups.
    Hargadon T
    Manag Care Q; 1999; 7(4):7-10. PubMed ID: 10661946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Consumer issues and threats to health care market reform.
    Pietzsch PM
    Manag Care Q; 1996; 4(4):49-57. PubMed ID: 10162550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Price fixing in provider networks: the evolution of the "messenger model".
    Roeder KH
    Ga Hosp Today; 1995 Jun; 39(6):3. PubMed ID: 10152771
    [No Abstract]   [Full Text] [Related]  

  • 53. For PSOs, it's ... ready, set, go!
    Weissenstein E
    Mod Healthc; 1997 Nov; 27(47):34-6. PubMed ID: 10174834
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physician negotiations with managed care plans: a primer of antitrust pitfalls.
    Ronai SE; Hudner HK
    Conn Med; 1992 Oct; 56(10):571-6. PubMed ID: 1458883
    [No Abstract]   [Full Text] [Related]  

  • 55. M.D. Physicians of Southwest Louisiana, Inc.; analysis to aid public comment--FTC. Proposed consent agreement.
    Fed Regist; 1998 Jun; 63(121):34423-4. PubMed ID: 10180296
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health insurance purchasing alliances: monopsony threat or procompetitive Rx for health sector ills?
    Miller FH
    Cornell Law Rev; 1994 Sep; 79(6):1546-72. PubMed ID: 10141443
    [No Abstract]   [Full Text] [Related]  

  • 57. Kleinke's "Bleeding Edge" sees utility role for providers.
    Johnson DE
    Health Care Strateg Manage; 1998 Oct; 16(10):2-3. PubMed ID: 10187608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Striking out! Federal enforcers losing streak in antitrust cases shows need for new game plan.
    Hallam K
    Mod Healthc; 1998 Apr; 28(17):30-3. PubMed ID: 10179159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Period of adjustment. Health plans experiment with new clinical risk adjustment strategies.
    Med Netw Strategy Rep; 1998 Dec; 7(12):1-6. PubMed ID: 10345546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Marshfield antitrust ruling ignored full market analysis.
    Glassman ML
    Mod Healthc; 1995 Sep; 25(36):64. PubMed ID: 10145181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.